Pseudocowpox virus, a novel vector to enhance the therapeutic efficacy of antitumor vaccination

OBJECTIVE: Antitumor viral vaccines, and more particularly poxviral vaccines, represent an active field for clinical development and translational research. To improve the efficacy and treatment outcome, new viral vectors are sought, with emphasis on their abilities to stimulate innate immunity, to...

Descripción completa

Detalles Bibliográficos
Autores principales: Ramos, Rodrigo Nalio, Tosch, Caroline, Kotsias, Fiorella, Claudepierre, Marie‐Christine, Schmitt, Doris, Remy‐Ziller, Christelle, Hoffmann, Chantal, Ricordel, Marine, Nourtier, Virginie, Farine, Isabelle, Laruelle, Laurence, Hortelano, Julie, Spring‐Giusti, Clementine, Sedlik, Christine, Le Tourneau, Christophe, Hoffmann, Caroline, Silvestre, Nathalie, Erbs, Philippe, Bendjama, Kaidre, Thioudellet, Christine, Quemeneur, Eric, Piaggio, Eliane, Rittner, Karola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081486/
https://www.ncbi.nlm.nih.gov/pubmed/35573979
http://dx.doi.org/10.1002/cti2.1392

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9081486/
https://www.ncbi.nlm.nih.gov/pubmed/35573979
http://dx.doi.org/10.1002/cti2.1392

Ejemplares similares